Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission

| |
Nibourel O., Kosmider O., Cheok M., Boissel N., Renneville A., Philippe N, Dombret H, Dreyfus F, Quesnel B., Geffroy S., Quentin S., Roche-Lestienne C., Cayuela J-M., Roumier C., Fenaux P., Vainchenker W., Bernard O., Soulier J., Fontenay M., Preudhomme C. Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission . Blood, 19 August 2010, Vol. 116, No. 7, pp. 1132-1135. doi: 10.1182/blood-2009-07-234484

Genetic signature of breast cancer with lymphangitic spread to the chest wall: Results from a randomized phase II study...

| |
Curigliano, G., Alkalay, M., Locatelli, M.A., Fumagalli, L., Giudici, S., Bertolini, F., Galimberti, V., Viale, G., Nole, F., & Goldhirsch, A. Genetic signature of breast cancer with lymphangitic spread to the chest wall: Results from a randomized phase II study combining bevacizumab with oral vinorelbine plus capecitabine (BEVIX). Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 2010, 28(15_suppl):1078.

Inflammatory tumor microenvironment is associated with superior survival in hepatocellular carcinoma patients

| |
Chew, V., Tow, C., Teo, M., Wong, H.L., Chan, J., Gehring, A., Loh, M., Bolze, A., Quek, R., Lee, V.K.M., Lee, K.H., Abastado, J-P., Toh, H.C., & Nardin, A. Inflammatory tumor microenvironment is associated with superior survival in hepatocellular carcinoma patients. Journal of Hepatology, 2010; 52(3):370-379. doi:10.1016/j.jhep.2009.07.013.

Molecular Characterization of Invasive Subpopulations from an Esophageal Squamous Cell Carcinoma Cell Line

| |
Chen, Y-K., Chang, W-S.W., Wu, I-C., Li, L-H., Yang, S-F., Chen, J.Y-F., Hsu, M-C., Chen, S-H., Wu, D-C., Lee, J-M., Huang, C-H., Goan, Y-G., Chou, S-H., Huang, C-H., & Wu, M-T. Molecular Characterization of Invasive Subpopulations from an Esophageal Squamous Cell Carcinoma Cell Line. Anticancer Research, 2010; 30(3):727-736.

Immortalization of Human Carcinoma-Associated Fibroblasts from Primary Colorectal Carcinomas

| |
Chao, C., Carmical, J.R., Ives, K., Kolokoltsov, A., Davey, R., Townsend, C.M., & Hellmich, M.R. Immortalization of Human Carcinoma-Associated Fibroblasts from Primary Colorectal Carcinomas. Journal of Surgical Research, 2010; 158(2):268. doi:10.1016/j.jss.2009.11.275.

Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib

| |
Biagi, C., Astolfi, A., Masetti, R., Serravalle, S., Franzoni, M., Chiarini, F., Melchionda, F., & Pession, A. Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib. Leukemia, 2010. doi:10.1038/leu.2010.81.

Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin..

| |
Falini, B., Macijewski, K., Weiss, T., Bacher, U., Schnittger, S., Kern, W., Kolhmann, A., Klein, H-U., Vignetti, M., Piciocchi, A., Fazi, P., Martelli, M.P., Vitale, A., Pileri, S., Miesner, M., Santucci, A., Haferlach, C., Mandelli, F., & Haferlach, T. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1). Blood, 2010; 115(18):3776-3786. doi:10.1182/blood-2009-08-240457.

IGF2 overexpression in solitary fibrous tumours is independent of anatomic location and is related to loss of imprinting

| |
Hajdu, M., Singer, S., Maki, R.G., Schwartz, G.K., Keohan, M.L., & Antonescu, C.R. IGF2 overexpression in solitary fibrous tumours is independent of anatomic location and is related to loss of imprinting. The Journal of Pathology, 2010. doi:10.1002/path.2715.

Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia...

| |
Hockley, S.L., Morilla, A., Else, M., Dearden, C., Catovsky, D., Morgan, G.J., Matutes, E., & Gonzalez, D. Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma. Leukemia, 2010. doi:10.1038/leu.2010.44.

Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules...

| |
Hong, S-B., Oh, H.B., Valera, V.A., Stull, J., Ngo, D-T., Baba, M., Merino, M.J., Linehan, W.M., & Schmidt, L.S. Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling. Molecular Cancer, 2010, 9:160. doi: 10.1186/1476-4598-9-160.